Vaccinology Gets Help from Chemistry.
A recent report on the immunological activity of protein conjugates of synthetic lipoteicoic fragments from Clostridium difficile underpins the use of these molecules for the development of a vaccine. In a recent issue of Cell Chemical Biology, Broecker et al. (2016) illustrate the utility of glycoarray-based selection of bacterial carbohydrates with the potential to become vaccine candidates.
GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: roberto.x.adamo@gsk.com.
Roberto
R
Adamo
D001428:Bacterial Vaccines; D003015:Clostridium Infections; D006801:Humans; D008070:Lipopolysaccharides; D011134:Polysaccharides; D013682:Teichoic Acids; D000078782:Vaccinology
D001428:Bacterial Vaccines; D008070:Lipopolysaccharides; D011134:Polysaccharides; D013682:Teichoic Acids; C009900:lipoteichoic acid